Interestingly, the most tumorigenic subpopulation was found to be c-met/high/CD44+, with as few as 50 cells enough to develop pancreatic cancer in NOD/SCID mice, where the percentage of c-met and c-met/high cells ranged between 2–16%. The gene discussed is MET; the disease is pancreatic neoplasm.